What Would You Do With the FDA? Pt1
Featuring Donald Berry, Joe Kiani, Steve Nissen, Andrew von Eschenbach
What Would You Do With the FDA? Pt2
Featuring Donald Berry, Joe Kiani, Steve Nissen, Andrew von Eschenbach
What Would You Do With the FDA? Pt3
Featuring Donald Berry, Joe Kiani, Steve Nissen, Andrew von Eschenbach
Matthew Inman Wants His New Car: SXSW Forbes Exclusive
theoatmeal.com's Matthew Inman gears up for his SXSW 2013 keynote speech.
Chinese Economy: A Few Questions for Jing Ulrich
Managing director and chairman of global markets, China, for J.P. Morgan speaks with Tim Ferguson.
Source: Forbes.com
Three Tips for Leaders Under 30
Top insights for leaders under 30, based on the forthcoming Leading from the Edge.
Petraeus: What Does His Future Hold?
A look at his prospects after his fall in disgrace from a pinnacle of fame and achievement.
Hillary 2016?
Mike Ozanian and Rick Ungar discuss the future political implications of Obama's win.
Five Pivotal Social Media Election Moments
Throughout this election, social media has had its fun - from Big Bird to 'Binders Full of Women.'
Best And Worst Places For Election Coverage
Forbes' Jeff Bercovici talks about elections coverage.
Source: Forbes.com
Cultivating the next generation of AI innovators in a global tech hub
A few years ago, I had to make one of the biggest decisions of my life: continue as a professor at the University of Melbourne or move to another part of the world to help build a brand new university focused entirely on artificial intelligence. With the rapid development we have seen in AI over…The Download: mysterious exosomes, and AI’s e-waste issue
This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology. Exosomes are touted as a trendy cure-all. We don’t know if they work. There’s a trendy new cure-all in town—you might have seen ads pop up on social media or read rave reviews…Palmer Luckey’s vision for the future of mixed reality
This story originally appeared in The Algorithm, our weekly newsletter on AI. To get stories like this in your inbox first, sign up here. War is a catalyst for change, an expert in AI and warfare told me in 2022. At the time, the war in Ukraine had just started, and the military AI business was…Exosomes are touted as a trendy cure-all. We don’t know if they work.
There’s a trendy new cure-all in town—you might have seen ads pop up on social media or read rave reviews in beauty magazines. Exosomes are being touted as a miraculous treatment for hair loss, aging skin, acne, eczema, pain conditions, long covid, and even neurological diseases like Parkinson’s and Alzheimer’s. That’s, of course, if you…AI will add to the e-waste problem. Here’s what we can do about it.
Generative AI could account for up to 5 million metric tons of e-waste by 2030, according to a new study. That’s a relatively small fraction of the current global total of over 60 million metric tons of e-waste each year. However, it’s still a significant part of a growing problem, experts warn. E-waste is the…Source: MIT Technology Review
'Real' Buehler helps put Dodgers on cusp of title
Yanks, on brink, know they must 'shock the world'
Banchero scores 50, with 37 in 'magical first half'
Russ shows 'a little less rust' in Steelers' win
Sources: Jazz's Hendricks to miss rest of season
U-M QB Tuttle retires: Need to prioritize health
McCarthy on Diggs' media spat: 'Have to be better'
Source: ESPN